A Novel PIK3CA Hotspot Mutation in Isfahanian Breast Cancer Patients

被引:1
|
作者
Gharbi, Sedigheh [1 ]
Faghihi, Mehri [2 ]
Tavassoli, Manoochehr [1 ]
机构
[1] Univ Isfahan, Dept Biol, Fac Sci, Hezar Jarib, Isfahan, Iran
[2] Med Sci Univ Isfahan, Div Oncol, Esfahan, Iran
关键词
PIK3CA; PI3K; Breast cancer; Mutation; Akt; MAMMARY EPITHELIAL-CELLS; TRASTUZUMAB RESISTANCE; HIGH-FREQUENCY; PTEN LOSS; GENE; CARCINOMA; CONTRIBUTES; P110-ALPHA; CORRELATE; PATTERNS;
D O I
10.3109/07357907.2010.550593
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Somatic mutations of phosphatidylinositol 3-kinase (PI3K) catalytic subunit (PIK3CA) play an important role in tumorigenesis. Using PCR-SSCP, followed by sequencing, we examined the PIK3CA gene over the previously identified mutational hotspots in a panel of 50 breast cancer and 5 normal breast tissue, as well as 50 normal blood samples isolated from a population of Iranian patients. In the present study, the frequency of PIK3CA mutation was 14%%. However, the previously identified hotspot mutations in exons 20 were completely absent in these breast cancer samples. Instead, we found a new hotspot mutation (3 of 50 samples) in exon 20.</.
引用
收藏
页码:313 / 317
页数:5
相关论文
共 50 条
  • [1] PIK3CA mutation profiling in Vietnamese patients with breast cancer
    Vuong, Linh Dieu
    Ta, To Van
    Chu, Ha Hoang
    Truong, Van-Long
    Nguyen, Quang Ngoc
    META GENE, 2020, 25
  • [2] Initiating breast cancer by PIK3CA mutation
    Miller, Todd W.
    BREAST CANCER RESEARCH, 2012, 14 (01):
  • [3] Initiating breast cancer by PIK3CA mutation
    Todd W Miller
    Breast Cancer Research, 14
  • [4] Mutation of the PIK3CA gene in ovarian and breast cancer
    Campbell, IG
    Russell, SE
    Choong, DYH
    Montgomery, KG
    Ciavarella, ML
    Hooi, CSF
    Cristiano, BE
    Pearson, RB
    Phillips, WA
    CANCER RESEARCH, 2004, 64 (21) : 7678 - 7681
  • [5] Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations
    Miranda, Adam X.
    Kemp, Justin
    Davidson, Brad A.
    Bellomo, Sara Erika
    Miranda, Verda E.
    Manoni, Alexandra
    Marchio, Caterina
    Croessmann, Sarah
    Park, Ben H.
    Hodges, Emily
    BMC GENOMICS, 2024, 25 (01):
  • [6] Adjuvant aromatase inhibitors in patients with PIK3CA mutation early breast cancer
    Reinhardt, K.
    Vetter, M.
    Kaufhold, S.
    Kantelhardt, E.
    Thomssen, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S296 - S296
  • [7] Comprehensive mutation profiling of PIK3CA gene in Indian breast cancer patients
    Kumar, R.
    Agrawal, U.
    Deo, S.
    Mathur, S. R.
    Gogia, A.
    Tanwar, P.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S33 - S33
  • [8] PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
    Kalinsky, Kevin
    Jacks, Lindsay M.
    Heguy, Adriana
    Patil, Sujata
    Drobnjak, Marija
    Bhanot, Umeshkumar K.
    Hedvat, Cyrus V.
    Traina, Tiffany A.
    Solit, David
    Gerald, William
    Moynahan, Mary Ellen
    CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5049 - 5059
  • [9] Circulating PIK3CA mutation detection at diagnosis in nonmetastatic inflammatory breast cancer patients
    Allouchery, V.
    Perdrix, A.
    Calbrix, C.
    Berghian, A.
    Lequesne, J.
    Fontanilles, M.
    Leheurteur, M.
    Etancelin, P.
    Vasseur, N. Sarafan
    Di Fiore, F.
    Clatot, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S344 - S345
  • [10] Natural history and outcome of patients presenting a metastatic breast cancer with PIK3CA mutation
    Mosele, Fernanda
    Verret, Benjamin
    Lusque, Amelie
    Filleron, Thomas
    Bachelot, Thomas
    Arnedos, Monica
    Campone, Mario
    Dalenc, Florence
    Lefeuvre, Claudia
    Sablin, Marie Paule
    Bonnefoi, Herve
    Lacroix, Ludovic
    Bieche, Ivan
    Goncalves, Anthony
    Jacot, William
    Jimenez, Marta
    Jacquet, Amelie
    Andre, Fabrice
    Andre, Fabrice
    CANCER RESEARCH, 2019, 79 (13)